
Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Kapoor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2009 - 2013
Ascension Illinois/Saint FrancisResidency, Internal Medicine, 2000 - 2003
Seth G.S. Medical CollegeClass of 1999
Certifications & Licensure
MN State Medical License 2004 - 2026
ND State Medical License 2004 - 2009
IL State Medical License 2000 - 2008
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2014-2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2014-2017
- CMS Meaningful Use Stage 2 Certification Centricity Patient Online, GE Healthcare, 2014-2017
Clinical Trials
- Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial Start of enrollment: 2021 May 06
- Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma Start of enrollment: 2017 Oct 25
Roles: Contact
Publications & Presentations
PubMed
- Multi-omics analysis reveals a unique epigenetic signature inwild-type Waldenström macroglobulinemia.Karan Chohan, Jonas Paludo, Surendra Dasari, Joseph P Novak, Jithma P Abeykoon
Haematologica. 2026-05-01 - POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia.Saurabh Zanwar, Jithma Abeykoon, Shirley D'Sa, Damien Roos-Weil, Dirk R Larson
Blood Advances. 2026-04-14 - Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front-Line Daratumumab Lenalidomide and Dexamethasone.Ricardo D Parrondo, Ricardo C B de Menezes, Hanna Sledge, Madhavi Nayyar, Kanika Yadav
American Journal of Hematology. 2026-04-01
Journal Articles
- Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple MyelomaS Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
- Safety and Efficacy of Propylene Glycol-Free Melphalan as Conditioning in Patients with AL Amyloidosis Undergoing Stem Cell TransplantationNelson Leung, Prashant Kapoor, Taxiarchis V Kourelis, Eli Muchtar, Angela Dispenzieri, M Hasib Sidiqi, Martha Q Lacy, Wilson I Gonsalves, Shaji K Kumar, Mohammed A Alj..., Nature
- Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of RelapseAngela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
Abstracts/Posters
- Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at DiagnosisPrashant Kapoor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Optimal Therapy for Relapsed AL Amyloidosis Post Autologous Stem Cell TransplantPrashant Kapoor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?Prashant Kapoor, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Minimal Residual Disease in Hematologic Malignancies: Testing Considerations and Challenges61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Development of Thrombocytopenia and Survival Outcomes in Newly Diagnosed Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Long-Term Survivorship with Active Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Simplified rIPSS-WM Improves Risk Stratification in Waldenström MacroglobulinemiaSeptember 9th, 2024
Predictors of Short-Term Survival in Waldenström MacroglobulinemiaJuly 14th, 2020
Researchers Devise a Progression Risk-Based Classification for Patients with Asymptomatic Waldenström MacroglobulinemiaApril 23rd, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









